HealthEquity (NASDAQ:HQY) Raised to “Buy” at Wall Street Zen
by Doug Wharley · The Cerbat GemHealthEquity (NASDAQ:HQY – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.
HQY has been the subject of a number of other reports. Barrington Research cut their price objective on HealthEquity from $125.00 to $110.00 and set an “outperform” rating for the company in a research report on Wednesday, March 18th. Barclays cut their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. Raymond James Financial set a $100.00 price objective on HealthEquity in a research report on Tuesday, February 17th. UBS Group set a $110.00 price objective on HealthEquity in a research report on Tuesday, February 17th. Finally, The Goldman Sachs Group downgraded HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective for the company. in a research report on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $111.79.
Check Out Our Latest Research Report on HealthEquity
HealthEquity Price Performance
Shares of NASDAQ:HQY opened at $77.96 on Friday. The business has a 50-day moving average price of $79.67 and a 200 day moving average price of $88.90. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $6.59 billion, a price-to-earnings ratio of 31.69, a PEG ratio of 1.42 and a beta of 0.26. HealthEquity has a 12-month low of $72.76 and a 12-month high of $116.65.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The firm had revenue of $334.59 million during the quarter, compared to the consensus estimate of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The firm’s revenue was up 7.3% compared to the same quarter last year. Sell-side analysts expect that HealthEquity will post 2.32 EPS for the current year.
Hedge Funds Weigh In On HealthEquity
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in HealthEquity by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock valued at $828,883,000 after acquiring an additional 243,549 shares during the period. Wasatch Advisors LP boosted its holdings in HealthEquity by 4.5% during the 4th quarter. Wasatch Advisors LP now owns 6,589,646 shares of the company’s stock valued at $603,677,000 after acquiring an additional 281,971 shares during the period. Geode Capital Management LLC boosted its holdings in HealthEquity by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after acquiring an additional 5,671 shares during the period. Westfield Capital Management Co. LP boosted its holdings in HealthEquity by 13.7% during the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after acquiring an additional 235,794 shares during the period. Finally, William Blair Investment Management LLC purchased a new position in HealthEquity during the 4th quarter valued at about $169,956,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.